Inclusion Criteria : 
  -  outpatients 2 to 6 years of age;
  -  males and females who are physically healthy;
  -  diagnosis of autism spectrum disorder based on clinical evaluation and DSM - 5 criteria , and confirmed using the Autism Diagnostic Interview - Revised , and the Autism Diagnostic Observation Schedule;
  -  care provider who could reliably bring subject to clinic visits , could provide trustworthy ratings , and interacted with subject on a regular basis;
  -  ability of subject to swallow the compound;
  -  stable concomitant medications for at least 2 weeks ( 4 weeks if patient took fluoxetine ) ;
  -  no planned changes in psychosocial interventions during the open - label trial. 
Exclusion Criteria : 
  -  DSM - 5 diagnosis of schizophrenia , schizoaffective disorder , or psychotic disorder not otherwise specified;
  -  prior adequate trial of Esomeprazole;
  -  active medical problems such as unstable seizures , or significant physical illness ( e. g. , serious liver or renal pathology ) .